MRI after 12 weeks of therapy predicts complete pathologic response to neoadjuvant chemotherapy.
A total of 35 percent of cancers diagnosed after second-opinion review were not initially detected in the original interpretation.
Imaging tests overused to diagnose pure breast pain among women.
Follow-up procedures are ordered by clinicians largely because current tools often cannot provide diagnostic certainty in identifying cancerous breast masses.
Either automated or clinical BI-RADS may be used to inform women of their breast density.
False positives from stereotactic vacuum-assisted breast biopsies do not appear to dissuade women from continuing with regular screening afterward.
Supplemental MR imaging for women at higher risk for breast cancer is not done frequently enough.
More interval breast cancers detected when screening mammography recall rates are low.
Magnetic resonance imaging screening is not consistent with guidelines for women at low to moderate risk for breast cancer.
Screening performance with MR imaging and mammography depends on breast cancer risk category.